Accordingly, it has been shown that cisplatin treatment causes a decrease in Akt-mediated FOXO3 phosphorylation in colon cancer cells, resulting in its nuclear translocation and activation [182]. This evidence concerns the gene FOXO3 and malignant colon neoplasm.